What Happened?
Boulder, CO-based OnKure-Therapeutics Appointed Jason Leverone as Chief Financial Officer
About the Company
OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure`s drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenvironment such that checkpoint inhibition is optimized.
About the Person
Jason Leverone is Chief Financial Officer at OnKure Therapeutics. Previously, Jason held various senior HR leadership roles in the industry.
Info Source
News
Short Profile